Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene and Interferon Alfa-2b in Cutaneous T-Cell Lymphoma
NCT00030849Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2001
- Primary completion
- Sep 2004
- Modality
- Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of bexarotene, interferon alfa-2b in cutaneous T-cell lymphoma (CTCL), sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2001; status: completed.
02
Drugs
bexaroteneinterferon alfa-2b
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00030849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030849.